Myrexis Inc – MYREXIS, INC. Executive Severance and Change in Control Agreement (September 28th, 2011)
THIS EXECUTIVE SEVERANCE AND CHANGE IN CONTROL AGREEMENT (this Agreement), by and between Myrexis, Inc., a Delaware corporation (the Company), and Andrea Kendell (the Executive), is made as of September 22, 2011 (the Effective Date).
Myrexis Inc – September 22, 2011 Andrea Kendell [ADDRESS] Dear Andrea: (September 28th, 2011)
The Board of Directors (the Board) of Myrexis, Inc. (the Company) is pleased to offer you the position of Chief Financial Officer (the Offer). You will be expected to perform various duties consistent with this position, and you will report directly to the Chief Executive Officer. This Offer is conditioned on your acceptance of the terms set forth below in this letter (this Offer Letter).
Auxilium Pharmaceuticals, Inc. – Amendment No. 2 to the Nonqualified Stock Option Agreement of Auxilium Pharmaceuticals, Inc. (August 6th, 2010)
This Amendment No. 2 (the Amendment) is made by and between Auxilium Pharmaceuticals, Inc. (the Company), and Dennis Langer (the Grantee), as of June 3, 2010. Capitalized terms used herein and not otherwise defined shall have the meaning ascribed thereto in the Auxilium Pharmaceuticals, Inc. 2004 Equity Compensation Plan, as amended (the Plan).